PEAK6 Investments’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$26.5M Buy
223,400
+187,800
+528% +$17.3M 0.06% 273
2024
Q2
$2.86M Buy
+35,600
New +$3.25M 0.01% 1144
2024
Q1
Sell
-36,000
Closed -$3.8M 4064
2023
Q4
$3.8M Sell
36,000
-78,200
-68% -$7.88M 0.01% 1036
2023
Q3
$12.4M Buy
114,200
+55,000
+93% +$6.08M 0.06% 317
2023
Q2
$6.39M Buy
59,200
+53,200
+887% +$5.98M 0.03% 547
2023
Q1
$747K Sell
6,000
-40,100
-87% -$5.51M ﹤0.01% 2065
2022
Q4
$6.93M Sell
46,100
-64,600
-58% -$9.94M 0.04% 534
2022
Q3
$14.9M Sell
110,700
-28,300
-20% -$4.33M 0.06% 300
2022
Q2
$18.3M Buy
139,000
+39,800
+40% +$6.08M 0.04% 503
2022
Q1
$16.9M Sell
99,200
-200
-0.2% -$33.6K 0.04% 465
2021
Q4
$25.6M Buy
99,400
+34,500
+53% +$9.45M 0.05% 338
2021
Q3
$17.7M Buy
64,900
+51,400
+381% +$16.3M 0.04% 435
2021
Q2
$3.02M Buy
13,500
+13,000
+2,600% +$2.45M 0.01% 1509
2021
Q1
$55K Buy
+500
New +$53.1K ﹤0.01% 4456

Other funds holding BNTX

PEAK6 Investments's BNTX Position: Q3 2024 in Review

PEAK6 Investments sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 17,750 shares — an estimated $1.63M sold.

PEAK6 Investments first reported a position in BNTX in Q1 2021 and held it in 12 quarters. The position peaked at $57.9M in Q3 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • PEAK6 Investments reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 17,750 BioNTech shares in Q3 2024, an estimated $1.63M.
  • PEAK6 Investments first reported a position in BioNTech in Q1 2021 and held it in 12 quarters.
  • PEAK6 Investments's BioNTech position peaked at $57.9M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.